Research progress of PPARγ regulation of cholesterol and inflammation in Alzheimer's disease

被引:6
|
作者
Gu, Lili [1 ]
Ju, Yue [1 ]
Hu, Min [1 ]
Zheng, Miao [1 ]
Li, Qin [1 ]
Zhang, Xinyue [1 ]
机构
[1] Hangzhou Med Coll, Key Lab Neuropsychiat Drug Res Zhejiang Prov, Hangzhou 310013, Peoples R China
关键词
PPAR gamma; Alzheimer's disease; Cholesterol; Inflammation; ACTIVATED-RECEPTOR-GAMMA; A-BETA CLEARANCE; NF-KAPPA-B; LIPID RAFTS; INTRACEREBRAL HEMORRHAGE; HEMATOMA RESOLUTION; THERAPEUTIC TARGET; AMYLOID-BETA; IN-VITRO; EXPRESSION;
D O I
10.1007/s11011-022-01139-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Peroxidase proliferator receptors (PPARs) are defined as key sensors and regulators of cell metabolism, transcription factors activated by ligands, involved in lipid, glucose and amino acid metabolism, participating in the processes of cell differentiation, apoptosis, inflammation regulation, and acute and chronic nerve damage. Among them, PPAR gamma is expressed in different brain regions and can regulate lipid metabolism, mitochondrial disorders, oxidative stress, and cell apoptosis. It has anti-inflammatory activity and shows neuroprotection. The regulation of A beta levels in Alzheimer's disease involves cholesterol metabolism and inflammation, so this article first analyzes the biological functions of PPAR gamma, then mainly focuses on the relationship between cholesterol and inflammation and A beta, and elaborates on the regulation of PPAR gamma on key proteins and the corresponding molecules, which provides new ideas for the treatment of AD.
引用
收藏
页码:839 / 854
页数:16
相关论文
共 50 条
  • [21] Alzheimer's disease and cholesterol
    Yanagisawa, K
    SEIKAGAKU, 2002, 74 (06): : 455 - 460
  • [22] Cholesterol in Alzheimer's disease
    Duff, KE
    Gaynor, K
    Olm, V
    Petanceska, S
    Refolo, R
    Burns, M
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S567 - S567
  • [23] Cholesterol and Alzheimer's disease
    Gironés, X
    Alameda, F
    Lafuente, JV
    Zambón, D
    Serra, MA
    Girabent, M
    Cruz-Sánchez, FF
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 238 : S35 - S35
  • [24] Cholesterol, Aβ and Alzheimer's disease
    Hartmann, T
    TRENDS IN NEUROSCIENCES, 2001, 24 (11) : S45 - S48
  • [25] Cholesterol and Alzheimer's disease
    Wolozin, B
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2002, 30 : 525 - 529
  • [26] Cholesterol in Alzheimer's disease
    Shobab, LA
    Hsiung, GYR
    Feldman, HH
    LANCET NEUROLOGY, 2005, 4 (12): : 841 - 852
  • [27] Cholesterol and Alzheimer's disease
    不详
    JOURNAL OF ADVANCED NURSING, 1998, 27 (05) : 885 - 886
  • [28] Massachusetts Alzheimer's Disease Research Center: Progress and challenges
    Hyman, Bradley T.
    Growdon, John H.
    Albers, Mark W.
    Buckner, Randy L.
    Chhatwal, Jasmeer
    Gomez-Isla, Maria Teresa
    Haass, Christian
    Hudry, Eloise
    Jack, Clifford R., Jr.
    Johnson, Keith A.
    Khachaturian, Zaven S.
    Kim, Doo Yeon
    Martin, Joseph B.
    Nitsch, Roger M.
    Rosen, Bruce R.
    Selkoe, Dennis J.
    Sperling, Reisa A.
    St George-Hyslop, Peter
    Tanzi, Rudolph E.
    Yap, Liang
    Young, Anne B.
    Phelps, Creighton H.
    McCaffrey, Patricia G.
    ALZHEIMERS & DEMENTIA, 2015, 11 (10) : 1241 - 1245
  • [29] Research progress on humoral biomarkers of Alzheimer's disease: A review
    Zhang, Hao
    Fu, Xiaofeng
    Yang, Mengyu
    Song, Xiaowen
    Li, Min
    Wang, Xuezhen
    MEDICINE, 2024, 103 (30)
  • [30] Research and progress of focused ultrasound in the treatment of Alzheimer's disease
    Ma, Xishun
    Li, Tongxia
    Du, Lizhen
    Han, Tongliang
    FRONTIERS IN NEUROLOGY, 2023, 14